Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 25,126 shares at $19.35 ($486K) on 2023-06-16, disclosed to the SEC on 2023-06-16.
Scheduled sale ($486k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.35 | 12,563 | $243K | 50.0% |
| 2 | $19.35 | 12,563 | $243K | 50.0% |
| Total | $19.35 avg | 25,126 | $486K | 100% |
| Filing → |
| RCUS | SELL | 2025-10-08 | $1.3M | — | Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |